Oppenheimer Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
FAM
CCM
WRF
CS
CC
BG
Oppenheimer Asset Management's CDNA Position: Q1 2020 in Review
Oppenheimer Asset Management sold out of CareDx (CDNA) in Q1 2020, closing a stake of 1,024 shares — an estimated $22K sold.
Oppenheimer Asset Management first reported a position in CDNA in Q4 2018 and held it in 5 quarters. The position peaked at $22K in Q4 2019. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.
- Oppenheimer Asset Management reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
- Oppenheimer Asset Management sold 1,024 CareDx shares in Q1 2020, an estimated $22K.
- Oppenheimer Asset Management first reported a position in CareDx in Q4 2018 and held it in 5 quarters.
- Oppenheimer Asset Management's CareDx position peaked at $22K in Q4 2019.
- 144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.
Based on Oppenheimer Asset Management's 13F filing for Q1 2020, filed 8 May 2020.